Teenage Drug Hunter

An Oregon teenager spent a summer in a New York biochemistry lab helping to discover a novel molecule that could become the next commercial nonaddictive painkiller.

Written byDan Cossins
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WHIZ KID: Raghav Tripathi (center), who won a $10,000 scholarship at the 2012 Siemens Competition National Finals, with his mentor Stony Brook University professor Iwao Ojima (left), and PhD candidate William Berger, who assisted him with his project.COURTESY OF STONY BROOK UNIVERSITYRaghav Tripathi is a senior at Westview High School in Portland, Oregon, but he’s already a promising scientist. When the 17-year-old’s mother broke her leg in a skiing accident and refused to take painkillers for fear of becoming dependent, Tripathi began looking into the possibility of producing a nonaddictive alternative. He read about anandamide (AEA), a compound naturally released by the body to ease pain and inflammation. “I thought I could find some way to increase concentrations of this molecule,” he says.

A literature search led him to biochemists at Stony Brook University, New York, who were already doing similar research, so he e-mailed his resume along with a research proposal and asked to work with them. It was an audacious request. But Iwao Ojima, director of the Institute of Chemical Biology and Drug Discovery at Stony Brook, was so impressed by the quality of the proposal that he invited Tripathi to spend 2 months working in his lab in the summer of 2012. “He was clearly an exceptional student,” says Ojima.

The research Tripathi carried out that summer earned him a place in the finals of the Siemens Competition in Math, Science, and Technology, held in Washington, DC, where he was awarded 6th place and $10,000 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies